MethodAdded (g mL-1 )BCGBTB5.0 10 15 five.0 10Recovery 99.ten one hundred.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE
MethodAdded (g mL-1 )BCGBTB5.0 10 15 5.0 10Recovery 99.ten one hundred.20 99.40 99.30 99.50 one hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Confidence limitb four.955 0.021 10.02 0.078 14.91 0.173 four.965 0.026 9.95 0.09 20.10 0.231 Recovery 99.60 99.80 99.20 one hundred.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Self-assurance limitb 4.98 0.025 9.98 0.075 14.88 0.152 five.03 0.020 9.94 0.068 19.92 0.abMean of six determinations; RSD : percentage relative normal deviation; RE : percentage relative error. Self-confidence limit at 95 self-confidence level and five degrees of freedom ( = 2.571).Journal of Analytical Methods in ChemistryJournal of Analytical Methods in ChemistryTable 5: Determination of GMF in its pharmaceutical dosage types applying the regular addition strategy.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCG2.BCP2.BPB2.BTB5.MO4.0 8.0 12 2.0 6.0 ten 4.0 eight.0 12 four.0 8.0 12 5.0 10Factive tablets Flobiotic tablet GemiQue tablets Total identified (g mL-1 ) Recovery a SD Total discovered (g mL-1 ) Recovery SD Total discovered (g mL-1 ) Recovery SD five.96 99.30 0.78 five.98 99.60 0.67 6.02 100.30 0.51 9.91 99.10 1.02 ten.02 100.20 0.82 9.92 99.20 0.70 13.97 99.80 1.24 13.96 99.70 1.09 13.99 99.90 0.94 three.996 99.90 0.66 3.96 99.10 0.42 3.97 99.30 0.38 8.02 100.20 0.90 7.98 99.80 0.69 7.99 99.90 0.84 11.92 99.30 0.95 12.05 100.40 1.03 11.95 99.60 1.17 five.97 99.50 0.57 5.99 99.80 0.36 6.01 100.15 0.76 9.97 99.70 0.76 9.96 99.60 0.49 9.97 99.70 0.96 13.87 99.ten 1.14 13.97 99.90 0.78 13.89 99.20 1.21 six.03 100.50 0.48 6.01 one hundred.10 0.53 six.01 100.10 0.54 9.90 99.00 0.72 9.96 99.60 0.85 9.96 99.60 1.03 13.93 99.50 0.97 13.96 99.70 1.31 14.04 one hundred.30 1.15 9.97 99.70 0.32 9.91 99.ten 0.70 9.99 99.90 0.65 14.94 99.60 0.56 15.06 one hundred.40 1.05 14.97 99.80 0.85 24.95 99.80 0.90 24.88 99.50 1.25 24.90 99.60 1.aAverage of six PKCθ Compound determinations.Table 6: Determination of MXF in its pharmaceutical dosage forms applying the regular addition strategy.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )2.BCP2.BPB2.BTB5.MO2.0 6.0 ten 4.0 8.0 12 two.0 four.0 eight.0 five.0 10Avelox tablets αvβ5 web Moxiflox tablets Moxifloxacin tablets Total identified (g mL-1 ) Recovery a SD Total located (g mL-1 ) Recovery SD Total discovered (g mL-1 ) Recovery SD 3.98 99.40 0.56 3.96 99.10 0.62 3.98 99.60 0.48 7.98 99.70 0.83 8.06 one hundred.70 0.89 7.98 99.80 1.ten 11.89 99.ten 1.20 12.02 one hundred.20 1.26 11.92 99.30 1.17 5.98 99.60 0.61 5.97 99.50 0.35 5.96 99.30 0.36 9.99 99.90 0.84 9.96 99.60 0.60 9.99 99.90 0.63 14.07 one hundred.50 1.14 13.99 99.90 0.85 14.08 one hundred.60 1.36 three.98 99.50 0.48 three.97 99.20 0.33 four.01 one hundred.20 0.61 five.95 99.20 0.92 5.99 99.80 0.65 5.96 99.30 0.84 ten.04 one hundred.40 1.17 10.01 one hundred.10 0.93 9.95 99.50 1.07 9.91 99.10 0.42 9.94 99.40 0.37 9.95 99.50 0.45 15.08 one hundred.50 0.76 15.03 100.20 0.75 14.97 99.80 0.85 19.90 99.50 1.16 19.92 99.60 1.28 19.83 99.15 0.Journal of Analytical Procedures in ChemistryaAverage of six determinations.Journal of Analytical Strategies in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage forms applying the typical addition approach. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) five.0 BCG five.0 BBTBa5.0 ten 15 five.0 10Enrocin 10 injectable Avitryl 20 injectable Total located (g mL-1 ) Recovery a SD Total found (g mL-1 ) Recovery SD 9.92 99.20 0.48 9.94 99.40 0.46 14.94 99.60 0.66 15.20 100.ten 0.72 19.98 10.05 14.91 19.84 99.90 0.82 one hundred.50 0.56 99.40 0.83 99.20 1.20 19.90 9.97 15.05 19.82 99.50.
bet-bromodomain.com
BET Bromodomain Inhibitor